Can one test positive after consuming CBD?

With CBD gaining both popularity and acceptance, more people are becoming interested in its therapeutic benefits. This is leading to an increasing number of consumers asking whether they will fail drug tests if they consume CBD. In principle, the answer is no, as it is THC, not CBD, that is tested for in drug tests. In practice, the answer depends on the QC of the product manufacturer.

More and more people are consuming CBD, due to its considerable therapeutic properties. CBD is a cannabinoid found in both hemp and cannabis. It has great therapeutic significance, as it is now used as a treatment for many diseases, including epileptic seizures such as West syndrome, anxiety disorders, and others. CBD also inhibits the transmission of nerve signals associated with pain!

CBD is also a topic gathering a lot of attention now, and there are regulatory and research development happening every day. Follow the latest news by downloading the companion Hemp.im cannabis and CBD news app.

Why are saliva tests used for THC testing?

With the growing general interest in CBD, many users are concerned about testing positive on a drug test. Today, this type of testing is quite common, whether it’s during traffic stops, or for professional reasons. People who are increasingly turning away from prescription drugs to CBD are not doing so with the intention of getting high. That’s why they are very concerned when faced with a drug test.

Beyond traffic stops to combat drug and alcohol use while driving, many companies are testing their employees for drugs. Recently, saliva tests are being used as a faster and cheaper way to detect THC use. There is a lot to know about CBD use and saliva testing, so it is important to know how they work and what they are able to detect.

Can CBD products be detected in a saliva test?

Before proceeding, it’s worth noting that CBD has no psychoactive effects, unlike THC. In fact, CBD acts as a modulator of THC, reducing its effects. In most countries of the European Union, it is, therefore, a completely legal compound. It is also known to slow down the rate at which THC is eliminated from the body. This is because it interferes with the metabolism of THC in the liver. It also does not seem to affect cannabinoid receptors, either CB1 or CB2.

Saliva tests are relatively new, are quite different from the standard urine test and are mostly supposed to be more accurate. Regardless, it is a quick, cheap and easy method of testing, so you can expect it to be used more and more in the workplace. That’s why it’s more important than ever to know how saliva testing works and what you can do to minimize your chances of failure.

CBD products are usually extracted from hemp strains, to avoid THC content. These products do not exceed the legal limit of 0.2% THC, so they are completely safe. Therefore, when purchasing CBD products, whether it’s oil, e-liquids, infusions, etc., you should always make sure you’re consuming products from reliable sources.

Is it possible to test positive for THC if you have consumed CBD?

In principle, it is not possible to test positive for THC if you have consumed CBD, as drug tests only measure the THC cannabinoid molecules present in urine or saliva. However, many CBD products may contain traces of THC, the main cannabinoid with psychoactive effects in cannabis.

Therefore, when performing a saliva test, the percentage of THC must be taken into account. It is possible that if the level is more than 1% THC, your test will be positive for this cannabinoid, even if you do not feel the full effects. If you have only consumed CBD products that guarantee no THC, it is more than likely that any test will be negative.

It is unusual for consumption of a product containing less THC than allowed by law, less than 0.2% in France, to test positive on a drug test in which the amount of THC in saliva or urine is examined. As always, it depends on the quality of the concentrate and the reliability of the seller.

—

(Featured image by CRYSTALWEED cannabis via Unsplash)

DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Hemp.im, its management, staff or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in 6actualités, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Hemp.im assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Hemp.im is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.

Anne Kings

Anne Kings is a reporter for the financial sector, often tackling Wall Street and shareholders' interests. She also covers the intersection of media and technology, and delves into interesting topics on entertainment. Sometimes she also writes about the cannabis industry, in particular CBD and hemp. She is currently based in New York.